产品介绍
戊型病毒性肝炎是一种自愈性传染病，其传播方式、临床表现和预后均与甲型肝炎(甲肝)类似，孕妇患戊肝病死率高为本型肝炎的特点。
|
EV64
|
rAg
|
|
E.coli
|
包被/标记
|
酶免、发光、层析
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human CD66c/CEACAM6 Recombinant Antibody , FITC|抗人CD66c/CEACAM6重组抗体，FITC(靶标：人CD66c（CEACAM-6）) |
370 |
| Anti-Human CD66c/CEACAM6 Recombinant Antibody, FITC|抗人CD66c/CEACAM6重组抗体，FITC(靶标：人CD66c（CEACAM-6）) |
423 |
| Anti-Human CD96 Recombinant Antibody, FITC|抗人CD96重组抗体，FITC(靶标：人CD96) |
500 |
| Anti-Human CD96 Recombinant Antibody , FITC|抗人CD96重组抗体，FITC(靶标：人CD96) |
344 |
| Anti-Mouse CD96 Recombinant Antibody , FITC|抗小鼠CD96重组抗体，FITC(靶标：小鼠CD96) |
462 |
| Anti-Mouse CD96 Recombinant Antibody , FITC|抗小鼠CD96重组抗体，FITC(靶标：小鼠CD96) |
387 |
| Anti-Human THPO Recombinant Antibody , FITC|抗人THPO重组抗体，FITC(靶标：人血小板生成素) |
423 |
| Anti-Human CD110/MPL Recombinant Antibody, FITC|抗人CD110/MPL重组抗体，FITC(靶标：人血小板生成素受体（MPL）) |
440 |
| Anti-Human CD110/MPL Recombinant Antibody, FITC|抗人CD110/MPL重组抗体，FITC(靶标：人血小板生成素受体（MPL）) |
418 |
| Anti-Human CD79β/CD79B Recombinant Antibody , FITC|抗人CD79β/CD79B重组抗体，FITC(靶标：人CD79B) |
256 |
| Anti-Human CD79β/CD79B Recombinant Antibody , FITC|抗人CD79β/CD79B重组抗体，FITC(靶标：人CD79B) |
279 |
| Anti-Mouse CD79b Recombinant Antibody, FITC|抗小鼠CD79b重组抗体，FITC(靶标：小鼠CD79B) |
491 |
| Anti-Human IL15 Recombinant Antibody , FITC|抗人IL15重组抗体，FITC(靶标：人白细胞介素-15) |
351 |
| Mouse Anti-Human PMEL17/ME20M Recombinant Antibody, FITC|小鼠抗人PMEL17/ME20M重组抗体，FITC(靶标：人前黑素体蛋白17) |
148 |
| Anti-Human CD200 Recombinant Antibody, FITC|抗人CD200重组抗体，FITC(靶标：人CD200) |
320 |
| Anti-Human CD200 Recombinant Antibody, FITC|抗人CD200重组抗体，FITC(靶标：人CD200) |
257 |
| Anti-Human ADCYAP1R1 Recombinant Antibody , FITC|抗人ADCYAP1R1重组抗体，FITC(靶标：人垂体腺苷酸环化酶激活肽1型受体) |
200 |
| Anti-Human CD192/CCR2 Recombinant Antibody, FITC|抗人CD192/CCR2重组抗体，FITC(靶标：人CCR2趋化因子受体) |
482 |
| Anti-Human CD86/B7-2 Recombinant Antibody, FITC|抗人CD86/B7-2重组抗体，FITC(靶标：人CD86（B7-2）) |
146 |
| Anti-Human CD86/B7-2 Recombinant Antibody , FITC|抗人CD86/B7-2重组抗体，FITC(靶标：人CD86（B7-2）) |
303 |
